Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells
Abstract Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MDR) cancer. In the present study, a clinically used...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2019-08-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-019-48169-2 |